The Board of Directors of An Phat Bioplastics Joint Stock Company approved a plan for the use of capital from the share issue for exercising the warrants which were issued in conjunction with bonds as follows:
− All proceeds of 560,000,000,000 dongs from the share issue for exercising the warrants which were issued in conjunction with bonds, which were adopted by the 2018 extraordinary general meeting of shareholders dated October 10, 2018, including capital surplus, will be used for the following purposes: